BRPI0216042B8 - polipeptídeo capaz de se ligar a ang-2, vetor de expressão, célula hospedeira, composição farmacêutica, e, uso dos referidos polipeptídeos. - Google Patents

polipeptídeo capaz de se ligar a ang-2, vetor de expressão, célula hospedeira, composição farmacêutica, e, uso dos referidos polipeptídeos.

Info

Publication number
BRPI0216042B8
BRPI0216042B8 BRPI0216042A BRPI0216042A BRPI0216042B8 BR PI0216042 B8 BRPI0216042 B8 BR PI0216042B8 BR PI0216042 A BRPI0216042 A BR PI0216042A BR PI0216042 A BRPI0216042 A BR PI0216042A BR PI0216042 B8 BRPI0216042 B8 BR PI0216042B8
Authority
BR
Brazil
Prior art keywords
ang
polypeptides
binding
pharmaceutical composition
host cell
Prior art date
Application number
BRPI0216042A
Other languages
English (en)
Inventor
Min Hosung
Daniel Oliner Jonathan
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/269,695 external-priority patent/US7138370B2/en
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of BRPI0216042B1 publication Critical patent/BRPI0216042B1/pt
Publication of BRPI0216042B8 publication Critical patent/BRPI0216042B8/pt

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

polipeptídeo capaz de se ligar a ang-2, vetor de expressão, célula hospedeira, composição farmacêutica, e, uso dos referidos polipeptídeos. são divulgados peptídeos que se ligam à ang-2. também são divulgados pepticorpos que compreendem os peptídeos, métodos de fabricar tais peptídeos e pepticorpos e métodos de tratamento que usam tais peptídeos e pepticorpos.
BRPI0216042A 2001-10-11 2002-10-11 polipeptídeo capaz de se ligar a ang-2, vetor de expressão, célula hospedeira, composição farmacêutica, e, uso dos referidos polipeptídeos. BRPI0216042B8 (pt)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US32862401P 2001-10-11 2001-10-11
US60/328624 2001-10-11
US41415502P 2002-09-27 2002-09-27
US60/414155 2002-09-27
US10/269,695 US7138370B2 (en) 2001-10-11 2002-10-10 Specific binding agents of human angiopoietin-2
US10/269695 2002-10-10
PCT/US2002/032657 WO2003057134A2 (en) 2001-10-11 2002-10-11 Specific binding agents of human angiopoietin-2
BRPI0213223 2002-10-11

Publications (2)

Publication Number Publication Date
BRPI0216042B1 BRPI0216042B1 (pt) 2019-05-21
BRPI0216042B8 true BRPI0216042B8 (pt) 2021-05-25

Family

ID=67259770

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0216042A BRPI0216042B8 (pt) 2001-10-11 2002-10-11 polipeptídeo capaz de se ligar a ang-2, vetor de expressão, célula hospedeira, composição farmacêutica, e, uso dos referidos polipeptídeos.

Country Status (1)

Country Link
BR (1) BRPI0216042B8 (pt)

Also Published As

Publication number Publication date
BRPI0216042B1 (pt) 2019-05-21

Similar Documents

Publication Publication Date Title
BR0009206A (pt) Isolamento e análise de proteina
DE60041505D1 (de) Inzektizide proteinen von bacillus thuringiensis
BR0013231A (pt) Complexos citocina-anticorpo múltiplos
DK0643726T3 (da) Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei
ATE500323T1 (de) Subtilisin-variante
PT871702E (pt) Citocina designada lerk-7
IL161016A (en) Polypeptides capable of ang-2 binding
ATE255906T1 (de) Antikörper gegen cd40
CA2295219A1 (en) Integrin binding peptide and use thereof
DE60030450D1 (de) Von MUC-1 abgeleitete Peptide
ATE551048T1 (de) Proteinhydrolysate enthaltende kosmetische zusammensetzungen
DK1017715T3 (da) Kimært polypeptid der omfatter fragment B af shiga-toksin og peptider af terapeutisk interesse
BR0312889A (pt) Polipeptìdeo t20 peguilado
ATE323763T1 (de) Dna & protein bindende miniatur proteine
DE60118359D1 (de) Humanische pellino-polypeptide
FI971896A7 (fi) BMP-tyyppi II-reseptoria koodaava cDNA
DK0707473T3 (da) Orale farmaceutiske præparater omfattende et protein eller et peptid, et antistof og polymerkugler
DK1539221T3 (da) Transferrin-fusionsproteinbiblioteker
WO2000058465A3 (en) Flint polypeptide analogs
DK0968288T3 (da) z219a, en human homolog til 2-19 protein
BRPI0216042B8 (pt) polipeptídeo capaz de se ligar a ang-2, vetor de expressão, célula hospedeira, composição farmacêutica, e, uso dos referidos polipeptídeos.
EA200400392A1 (ru) Связывающий каспазу-8 белок, его получение и применение
WO2002055669A3 (en) Regulation of target protein activity through modified proteins
ES2185652T3 (es) Oligopeptidos derivados de fragmentos de proteinas c-reactiva.
FI971086A7 (fi) Kinaasia sitova proteiini ja sen käyttö

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/05/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/05/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/10/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 11/10/2022